Wedelolactone inhibits breast cancer-induced osteoclastogenesis by decreasing Akt/mTOR signaling
Publisher: Spandidos Publications
E-ISSN: 1791-2423|46|2|555-562
ISSN: 1019-6439
Source: International Journal of Oncology, Vol.46, Iss.2, 2015-01, pp. : 555-562
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract